KDR and breast carcinoma: After in situ screening of the library for cytotoxic activity against breast cancer cell line MCF-7 and evaluation of VEGFR-2 enzyme inhibition, the authors concluded that compounds 151d, 151h, and 151o were the most potent (Scheme 21D).